Venous Thromboembolism and Secondary Outcomes of Bleeding and Mortality in Patients with Gliomas: A Multicenter Cohort Study - Takeaways - MDSpire

Venous Thromboembolism and Secondary Outcomes of Bleeding and Mortality in Patients with Gliomas: A Multicenter Cohort Study

  • By

  • Veiga, Viviane Cordeiro

  • Yamada, Camilla A. F.

  • Clara, Carlos Afonso

  • Santos, Jéssica Carolina Andrade

  • Milano, Breno Gray

  • Matias, Danielli Almeida

  • Melo, Pedro Hortêncio Saboia da Escossia

  • Batistella, Gabriel Novaes de Rezende

  • Cavalcanti, Alexandre Biasi

  • Viola, Fabiana Spillari

  • Levy, Ana Carolina

  • Santos, Silvana Soares

  • Fittipaldi, Carolina

  • Pinto, Mauro Bráulio da Rosa

  • Oliveira, Daniela Galvão Barros

  • Vieira, Thiago Santos

  • Moraes, Flavia Regina

  • Ostolin, Thatiane Lopes Valentim Di Paschoaele

  • Belucci, Talita Rantin

  • Chaddad-Neto, Feres

  • Baeta, Alex Machado

  • Neville, Iuri Santana

  • Peres, Stela Verzinhasse

  • April 30, 2026

  • 0 min

Share

  • 1

    The study analyzed 334 glioma patients across nine Brazilian centers to assess venous thromboembolism (VTE), bleeding, and mortality.

  • 2

    The 12-month cumulative incidence of VTE was 11.8%, while bleeding incidence was 4.7%, and cumulative mortality was 26.2%.

  • 3

    Prior VTE and corticosteroid use significantly increased the risk of VTE, with chronic kidney failure and diabetes predicting bleeding.

  • 4

    Gliomas NOS and GBM were strongly associated with increased mortality risk, alongside factors like longer hospitalization and postoperative bleeding.

  • 5

    Higher educational levels correlated with lower mortality risk, while prolonged hospitalization and postoperative bleeding increased mortality across tumor grades.

Original Source(s)

Related Content